Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 105
Filter
1.
J Physiol Pharmacol ; 71(4)2020 Aug.
Article in English | MEDLINE | ID: mdl-33214335

ABSTRACT

Burkitt lymphoma (BL) is a highly aggressive form of non-Hodgkin's B-cell lymphoma. Currently, multi-agent chemotherapy regimens are being used to significantly improve cure rates and achieve complete remissions in BL patients. However, drug resistance can often occur within 6 months in BL patients, contributing to poor prognosis. Mounting evidence suggests that cell adhesion-mediated drug resistance (CAM-DR), caused by the interaction between the bone marrow microenvironment and tumour cells may play an important role in drug resistance to chemotherapy. However, the molecular mechanism underlying CAM-DR in BL has not been identified yet. In this study, we investigated the molecular mechanism responsible for CAM-DR in BL cells. We also examined the therapeutic targets of CAM-DR in BL cells and found CD49d and CD49e to be the important adhesion molecules involved. However, CD49a, CD49b, CD11a, CD29, CD18, and CD61 were not found to be associated with CAM-DR in BL cells. Furthermore, we clarified that CD49d- and CD49e-mediated CAM-DR could be attributed to an increase in the expression of B cell leukemia-xL (Bcl-xL) and survivin proteins, and a decrease in the expression of Bcl-2 associated X (Bax), Bcl-2 interacting mediator (Bim) and p53 upregulated modulator of apoptosis (PUMA) proteins via nuclear factor kappaB (NF-κB) activation. In addition, bortezomib was found to overcome CAM-DR in BL cells by inhibiting NF-κB. Thus, bortezomib may have potential clinical applications in the treatment of CD49d- and CD49e-mediated CAM-DR in BL patients.


Subject(s)
Antineoplastic Agents/pharmacology , Burkitt Lymphoma/drug therapy , Cell Adhesion/drug effects , Drug Resistance, Neoplasm , Integrin alpha4/metabolism , Integrin alpha5/metabolism , NF-kappa B/metabolism , Animals , Apoptosis Regulatory Proteins/metabolism , Bortezomib/pharmacology , Burkitt Lymphoma/immunology , Burkitt Lymphoma/metabolism , Cell Line, Tumor , Coculture Techniques , Humans , Mice , Mice, Inbred BALB C , Proteasome Inhibitors/pharmacology , Signal Transduction , Tumor Microenvironment
2.
Bone Marrow Transplant ; 48(2): 257-64, 2013 Feb.
Article in English | MEDLINE | ID: mdl-22750998

ABSTRACT

High incidences of human herpesvirus (HHV)-6 encephalitis have recently been reported from several Japanese SCT centers. To evaluate the effect of low-dose foscarnet (PFA) in preventing HHV-6 infection among recipients of unrelated BM or cord blood (CB), we examined consecutive cohorts without prophylaxis against HHV-6 (cohort 1, n=51) and with PFA prophylaxis (cohort 2, PFA 50 mg/kg/day for 10 days after engraftment, n=67). Plasma real-time PCR assay was performed weekly. High-level reactivation defined as HHV-6 DNA > or =10(4) copies/mL by day 70 was the primary endpoint. No significant reduction of high-level reactivation was seen in cohort 2 (19.4%) compared with cohort 1 (33.8%, P=0.095). A trend was identified toward fewer high-level HHV-6 reactivations in cohort 2 among recipients of unrelated BM (P=0.067), but no difference in incidence was observed among CB recipients (P=0.75). Breakthrough HHV-6 encephalitis occurred following PFA prophylaxis in three patients, and incidence of HHV-6 encephalitis did not differ between cohort 1 (9.9%) and cohort 2 (4.5%, P=0.24). In conclusion, 50 mg/kg/day of PFA does not effectively suppress HHV-6 reactivation and cannot prevent all cases of HHV-6 encephalitis. To effectively prevent HHV-6 encephalitis, alternative approaches based on the pathogenesis of HHV-6 encephalitis will probably be required.


Subject(s)
Antiviral Agents/therapeutic use , Encephalitis, Viral/drug therapy , Foscarnet/therapeutic use , Hematopoietic Stem Cell Transplantation/adverse effects , Hematopoietic Stem Cell Transplantation/methods , Herpesvirus 6, Human/physiology , Roseolovirus Infections/drug therapy , Adolescent , Adult , Aged , Cohort Studies , Encephalitis, Viral/etiology , Encephalitis, Viral/prevention & control , Encephalitis, Viral/virology , Humans , Incidence , Middle Aged , Roseolovirus Infections/etiology , Roseolovirus Infections/prevention & control , Roseolovirus Infections/virology , Transplantation, Homologous , Virus Activation/drug effects , Young Adult
3.
Eur Surg Res ; 47(4): 254-9, 2011.
Article in English | MEDLINE | ID: mdl-22067579

ABSTRACT

BACKGROUND: There is no standard treatment available for gastric cancer patients whose sole 'non-curative factor' is positivecytological findings in peritoneal washings (CFPW). The aim of this study was to examine the safety, pharmacokinetics and efficacy for free intraperitoneal cancer cells of intraperitoneal chemotherapy with paclitaxel after gastrectomy with en bloc D2 lymph node dissection in cases of gastric cancer with positive CFPW. METHODS: Ten patients with gastric cancer who underwent gastrectomy and systemic lymphadenectomy with D2 dissection, without any other non-curative factors besides positive CFPW, were treated with early postoperative intraperitoneal paclitaxel. Intra-chemotherapeutic toxicity and operative complications were measured using NCI-CTC version 3.0. Intraperitoneal and plasma paclitaxel concentrations were measured using a high-performance liquid chromatographic assay. RESULTS: Grade 3/4 toxic effects included anemia (20%) and neutropenia (10%) that required no treatment. Operative complications were, for example, superficial surgical site infections (10%) that were treated with antibiotics. No viable cancer cells were observed in the intra-abdominal fluid 24 h after intraperitoneal administration of paclitaxel. The intraperitoneal/plasma area under the drug concentration-time curve ratio was 2,003.3:1. CONCLUSION: Intraperitoneal chemotherapy with paclitaxel is a safe and effective treatment modality for free intraperitoneal cancer cells.


Subject(s)
Adenocarcinoma/drug therapy , Antineoplastic Agents/administration & dosage , Stomach Neoplasms/drug therapy , Adenocarcinoma/mortality , Adenocarcinoma/pathology , Adenocarcinoma/surgery , Aged , Antineoplastic Agents/pharmacokinetics , Antineoplastic Agents/toxicity , Antineoplastic Combined Chemotherapy Protocols , Female , Humans , Infusions, Parenteral , Male , Middle Aged , Peritoneal Cavity/pathology , Peritoneal Lavage , Prospective Studies , Stomach Neoplasms/mortality , Stomach Neoplasms/pathology , Stomach Neoplasms/surgery
4.
Eur J Surg Oncol ; 36(10): 963-8, 2010 Oct.
Article in English | MEDLINE | ID: mdl-20638818

ABSTRACT

BACKGROUND: We performed short-term neoadjuvant chemotherapy (s-NAC) to examine whether anticancer drugs can change the proliferative ability of cancer cells in gastric cancer patients. METHODS: Chemotherapy was performed for 72 h before gastrectomy in 63 gastric cancer patients. Patients were classed into four groups: Group F, 16 cases who received a single administration of 5-fluorouracil (5-FU); Group C, 15 cases who received a single administration of cis-diamminedichloroplatinum (CDDP; cisplatin); Group FC, 16 cases who received both 5-FU+CDDP; and a Control group, 16 cases who did not receive chemotherapy. We reviewed neoadjuvant biopsy tissue and gastric cancer tissue delivered by operation in these cases. The TUNEL method and immunohistochemistry with an anti-MIB-1 antibody were used to evaluate cellular apoptosis and proliferative ability, respectively. The apoptotic index (AI) and an MIB-1 index (MI) were also calculated. RESULTS: There were no differences in AI or MI in biopsy tissue between the groups. The AI of gastric cancer tissue in Group FC was significantly higher than in the other groups (P < 0.01). The MI of Group FC was significantly lower than in the other groups (P < 0.05). In addition, after s-NAC operation there was a significant inhibition of proliferative potency and an induction of apoptosis in Group FC. CONCLUSION: Combination of CDDP and 5-FU reduced proliferative potency and increased cellular apoptosis in gastric cancer cells.


Subject(s)
Antineoplastic Combined Chemotherapy Protocols/administration & dosage , Neoadjuvant Therapy/methods , Stomach Neoplasms/drug therapy , Stomach Neoplasms/pathology , Aged , Biopsy, Needle , Chi-Square Distribution , Cisplatin/administration & dosage , Dose-Response Relationship, Drug , Drug Administration Schedule , Female , Fluorouracil/administration & dosage , Follow-Up Studies , Gastrectomy/methods , Humans , Immunohistochemistry , Kaplan-Meier Estimate , Male , Middle Aged , Neoplasm Staging , Prospective Studies , Reference Values , Stomach Neoplasms/mortality , Stomach Neoplasms/surgery , Survival Rate , Treatment Outcome
5.
Kyobu Geka ; 63(5): 375-8, 2010 May.
Article in Japanese | MEDLINE | ID: mdl-20446605

ABSTRACT

Thymic carcinoma is rare. Particularly sarcomatoid carcinoma of the thymus is a very rare disease it has been reported in only 15 patients to date. The prognosis is very poor and diagnosis and treatment have not yet been established. We report a case of 63-year-old man who was initially diagnosed with acute pericarditis and was finally found to be sarcomatoid carcinoma of the thymus. He underwent surgery and the tumor was completely resected. However, 6 months after surgery, local recurrence was noted. The patient was treated by radiotherapy followed by paclitaxel monotherapy. Partial remission was achieved transiently with paclitaxel, but the tumor again recurred. He died 33 months after surgery. The possibility of diseases like this tumor must be kept in mind for a patient with chest symptoms. Paclitaxel monotherapy is likely to be effective in treating sarcomatoid carcinoma of the thymus.


Subject(s)
Carcinoma/complications , Thymus Neoplasms/complications , Acute Disease , Humans , Male , Middle Aged , Pericarditis/etiology
6.
Bone Marrow Transplant ; 45(1): 129-36, 2010 Jan.
Article in English | MEDLINE | ID: mdl-19465942

ABSTRACT

This study investigated factors associated with the development of human herpesvirus (HHV)-6 encephalitis. Among 111 enrolled subjects, 12 patients developed central nervous system (CNS) dysfunction. CNS dysfunction in four patients was found to have no association with HHV-6. The remaining eight patients displayed HHV-6 encephalitis (n=3), limbic encephalitis (HHV-6 DNA in cerebrospinal fluid was not examined; n=3) or CNS dysfunction because of an unidentified cause (n=2). Real-time PCR showed CNS dysfunction in the latter eight patients, which developed concomitant with the appearance of high plasma levels of HHV-6 DNA (> or =10(4) copies/ml). Overall, eight of the 24 patients with high-level HHV-6 DNA developed CNS dysfunction, whereas no patients developed CNS dysfunction potentially associated with HHV-6 infection if peak HHV-6 DNA was <10(4) copies/ml. We next analyzed plasma concentrations of IL-6, IL-10 and tumor necrosis factor-alpha among patients who displayed high-level plasma HHV-6 DNA and found elevated IL-6 concentrations preceding HHV-6 infection in patients who developed CNS dysfunction. (Mean+/-s.d.: 865.7+/-1036.3 pg/ml in patients with CNS dysfunction; 56.5+/-192.9 pg/ml in others; P=0.01). These results suggest that high-level HHV-6 load is necessary for the development of HHV-6 encephalitis, and systemic inflammatory conditions before HHV-6 infection form the preparatory conditions for progression to encephalopathy.


Subject(s)
Encephalitis, Viral/virology , Herpesvirus 6, Human , Interleukin-6/blood , Roseolovirus Infections/virology , Stem Cell Transplantation/adverse effects , Adolescent , Adult , Child , DNA, Viral/blood , Female , Herpesvirus 6, Human/genetics , Humans , Interleukin-10/blood , Male , Middle Aged , Tumor Necrosis Factor-alpha/blood , Viral Load
8.
Bone Marrow Transplant ; 41(3): 279-85, 2008 Feb.
Article in English | MEDLINE | ID: mdl-18037945

ABSTRACT

Human herpesvirus 6 (HHV-6) causes life-threatening encephalopathy in recipients of allogeneic SCT, but no consensus has been reached regarding appropriate preventive methods. This study evaluated a plasma HHV-6 viral load-guided preemptive approach against HHV-6-associated encephalopathy. Plasma real-time PCR assay was performed once a week. Among 29 patients, 19 developed positive plasma HHV-6 DNA. Median maximum plasma HHV-6 DNA was 4593.5 copies/ml plasma (range, 150.0-127 891.0 copies/ml plasma). In one of eight events with low-level HHV-6 DNA (defined as <1000 copies/ml plasma) and four of seven events with mid-level HHV-6 DNA (1000-9999.5 copies/ml plasma), HHV-6 loads in plasma subsequently continued increasing. Ganciclovir was administered against six of nine patients with high-level HHV-6 DNA (> or =10,000 copies/ml plasma). High-level HHV-6 DNA resolved similarly in both groups with or without ganciclovir therapy. Among the nine patients with high-level HHV-6 DNA two developed encephalopathy. As encephalopathy developed before the detection of high-level HHV-6 DNA in plasma, these two patients had not received preemptive ganciclovir therapy. In conclusion, our preemptive approach against HHV-6-associated encephalopathy cannot prevent all cases of HHV-6 encephalopathy in SCT recipients due to the dynamic kinetics of plasma HHV-6 viral load.


Subject(s)
Encephalitis, Viral/prevention & control , Hematopoietic Stem Cell Transplantation/adverse effects , Herpesvirus 6, Human/drug effects , Roseolovirus Infections/prevention & control , Viral Load , Adolescent , Adult , Antiviral Agents/therapeutic use , Chemoprevention , DNA, Viral/blood , Encephalitis, Viral/virology , Female , Ganciclovir/therapeutic use , Herpesvirus 6, Human/pathogenicity , Humans , Kaplan-Meier Estimate , Male , Middle Aged , Prospective Studies , Transplantation, Homologous/adverse effects , Treatment Outcome
9.
Bone Marrow Transplant ; 35(4): 403-10, 2005 Feb.
Article in English | MEDLINE | ID: mdl-15592493

ABSTRACT

Real-time PCR has many advantages compared with antigenemia and qualitative PCR assays for detecting cytomegalovirus (CMV) infection in patients following SCT. However, the procedure used in each report was not standardized. This study compares the CMV load detected by real-time PCR assays amplifying distinct genomic regions. Real-time PCR assays based on US17, UL65, immediate early protein (IE) and glycoprotein B(gB) were selected and comparisons were made between each genomic region, and with antigenemia and nested PCR (IE region) in 18 SCT patients. The CMV load detected by real-time PCR using all combinations of primers targeting distinct genomic regions and by antigenemia assays correlated well. However, US17 and UL65-PCR could detect CMV earlier than gB-PCR, antigenemia and nested PCR assays. In longitudinal analysis, gB-PCR demonstrated a trend for showing a lower viral load in some patients than US17-, UL65- and IE-PCR. Moreover, the results suggest that a cutoff level of 500 copies/ml might be used to decide when to initiate treatment. We propose that monitoring should be carried out using real-time PCR assays targeting the US17 region and that a CMV load of 500 copies/ml could be used as a cutoff value for initiating treatment in patients following SCT, receiving immunoglobulin prophylaxis.


Subject(s)
Cytomegalovirus Infections/diagnosis , Cytomegalovirus/genetics , Genome, Viral , Hematopoietic Stem Cell Transplantation , Polymerase Chain Reaction , Virus Activation , Adult , Cytomegalovirus Infections/genetics , Female , Humans , Male , Middle Aged , Polymerase Chain Reaction/methods , Predictive Value of Tests , Sensitivity and Specificity , Virus Activation/genetics
10.
Surg Endosc ; 18(3): 383-9, 2004 Mar.
Article in English | MEDLINE | ID: mdl-14735343

ABSTRACT

BACKGROUND: Transthoracic esophagectomy (TTE) is a radical strategy for treatment of esophageal cancer, and the morbidity and mortality are high. Transhiatal esophagectomy (THE) is advantageous because it avoids thoracotomy and has a shorter surgical time, but risk of intraoperative morbidity stresses the surgeon and lymph node sampling is not possible. METHODS: Mediastinoscope-assisted transhiatal esophagectomy (MATHE) was performed in 42 patients with esophageal cancer. Patients with superficial esophageal cancer and medical risk were included. Feasibility and efficacy of this procedure are discussed by examining short- and long-term morbidity, mortality, and survival. RESULTS: With the mediastinoscope, esophagectomy was performed safely under direct vision. There was only a small amount of bleeding, and surgical time was short. Little morbidity and no deaths were recorded. CONCLUSION: MATHE is a safe and minimally invasive technique that allows direct visualization of mediastinal structures Lymph node sampling was feasible because of clear visualization of the mediastinum.


Subject(s)
Adenocarcinoma/surgery , Carcinoma, Squamous Cell/surgery , Esophageal Neoplasms/surgery , Esophagectomy/methods , Mediastinoscopy/methods , Adenocarcinoma/mortality , Adenocarcinoma/pathology , Adult , Aged , Aged, 80 and over , Biopsy , Carcinoma, Squamous Cell/mortality , Carcinoma, Squamous Cell/pathology , Comorbidity , Diaphragm , Esophageal Neoplasms/mortality , Esophageal Neoplasms/pathology , Feasibility Studies , Female , Humans , Lymph Nodes/pathology , Lymphatic Metastasis , Male , Middle Aged , Minimally Invasive Surgical Procedures , Neoplasm Invasiveness , Pneumonia, Aspiration/epidemiology , Postoperative Complications/mortality , Risk , Vocal Cord Paralysis/epidemiology , Vocal Cord Paralysis/etiology
11.
Clin Rheumatol ; 22(1): 45-8, 2003 Feb.
Article in English | MEDLINE | ID: mdl-12605318

ABSTRACT

We describe a rare case of a 46-year-old Japanese man with dermatomyositis (DM) and interstitial lung disease who developed spontaneous pneumomediastinum and subcutaneous emphysema. Relatively mild myositis, mild elevation of CK values and the absence of anti-Jo-1 antibody were observed and the case was similar to amyopathic DM. Treatment of this patient with oral prednisolone and cyclosporin A (CsA) was effective for the myositis and interstitial lung disease. The administration of CsA enabled rapid tapering of the dose of prednisolone without aggravating the disease. Pneumomediastinum and subcutaneous emphysema disappeared 5 months later without recurrence. The serum levels of KL-6 were monitored every 2 weeks to help determine whether this may have contributed to the recurrence of interstitial pneumonitis. This is a rare case of pneumomediastinum in a patient with DM.


Subject(s)
Cyclosporine/therapeutic use , Dermatomyositis/complications , Dermatomyositis/drug therapy , Mediastinal Emphysema/etiology , Administration, Oral , Anti-Inflammatory Agents/administration & dosage , Antigens/blood , Antigens, Neoplasm , Cyclosporine/administration & dosage , Dose-Response Relationship, Drug , Drug Administration Schedule , Glycoproteins/blood , Humans , Lung Diseases, Interstitial/drug therapy , Lung Diseases, Interstitial/etiology , Lung Diseases, Interstitial/immunology , Male , Mediastinal Emphysema/diagnostic imaging , Middle Aged , Mucin-1 , Mucins , Prednisolone/administration & dosage , Radiography, Thoracic , Tomography, X-Ray Computed
12.
Exp Toxicol Pathol ; 53(4): 303-8, 2001 Sep.
Article in English | MEDLINE | ID: mdl-11665855

ABSTRACT

We investigated the effects of a 7 day repetitive administration of tetrabenazine (TBZ), which depletes monoamines, on both locomotor behavior and histomorphometrial findings of substantia nigra in rats. These results were compared with the effects of a single dose of TBZ, which is a common paradigm in animal models of depression. A single dose of TBZ causes reversible decrease of voluntary movement and no histological changes. In contrast, as for repetitive administration, this experiment demonstrated irreversible and significant decrease in spontaneous locomotion, as well as histological changes in the neurons of the substantia nigra pars compacta. These results have led us to propose that prolonged TBZ administration could provide a novel and useful model for the behavioral characteristics and anatomical pathology of Parkinson's disease as one of the oxidative stress models induced by abnormal dopamine metabolism.


Subject(s)
Adrenergic Uptake Inhibitors/toxicity , Locomotion/drug effects , Substantia Nigra/drug effects , Tetrabenazine/toxicity , Adrenergic Uptake Inhibitors/administration & dosage , Animals , Cell Count , Cell Size/drug effects , Drug Administration Schedule , Glial Fibrillary Acidic Protein/analysis , Image Processing, Computer-Assisted , Immunohistochemistry , Male , Neurons/drug effects , Neurons/pathology , Rats , Rats, Wistar , Substantia Nigra/chemistry , Substantia Nigra/pathology , Tetrabenazine/administration & dosage
14.
Vet Parasitol ; 99(4): 311-22, 2001 Aug 31.
Article in English | MEDLINE | ID: mdl-11511418

ABSTRACT

With the aim of developing therapeutic agents for strongyloidosis, the disease caused by infection with Strongyloides stercoralis, we established a novel assay technique using S. ratti and S. venezuelensis as models for S. stercoralis. The newly developed assay technique was found to more accurately represent treatment-induced larval paralysis than existing assays. Our method uses paper disks impregnated with the test solution, which even allows materials that are sparingly soluble in water to be tested. An inverted microscope was used to observe the larval states, and these states were recorded using a digital camera. We observed the activities of ivermectin and thiabendazole against larvae and calculated larval motility and velocity. These two factors were then combined to determine the overall viability of larvae at selected concentrations. The activities of the anthelmintics were compared by calculating the concentrations at which 50% viability was demonstrated, or in other words, the concentration at which paralysis was caused in 50% of the individuals (50% paralysis concentration; PC(50)). Evaluations after 24h of exposure yielded the following reproducible PC(50) values for ivermectin and thiabendazole, respectively: S. ratti, 2.4 and 140 microM; and S. venezuelensis, 2.3 and 190 microM. After treatment with ivermectin, there was a tendency for larval motility to be greater than that of the controls at low concentrations, a result that might be associated with its mechanism of action.


Subject(s)
Antinematodal Agents/pharmacology , Ivermectin/pharmacology , Strongylida Infections/drug therapy , Strongyloides/drug effects , Thiabendazole/pharmacology , Animals , Antinematodal Agents/therapeutic use , Feces/parasitology , Ivermectin/therapeutic use , Larva/drug effects , Larva/growth & development , Lethal Dose 50 , Rats , Strongyloides/growth & development , Strongyloides ratti/drug effects , Strongyloides ratti/growth & development , Thiabendazole/therapeutic use , Treatment Outcome
15.
Pathol Int ; 51(7): 555-9, 2001 Jul.
Article in English | MEDLINE | ID: mdl-11472569

ABSTRACT

We present the first report of bladder carcinoma that demonstrates a mixture of two distinct histological patterns resembling malignant lymphoma. The patient was a 79-year-old man. One of the histological patterns was a diffuse growth of monomorphic carcinoma cells, and the other was a dense lymphoplasmacytic infiltrate, obscuring the carcinoma. The tumor cells showing both patterns expressed cytokeratin and epithelial membrane antigen, but not lymphoid markers. Careful immunohistochemical evaluation should be done when diagnosing urinary bladder carcinomas resembling lymphomas (other than primary lymphomas).


Subject(s)
Carcinoma/diagnosis , Lymphoma/diagnosis , Urinary Bladder Neoplasms/diagnosis , Aged , Carcinoma/chemistry , Carcinoma/surgery , Diagnosis, Differential , Humans , Immunoenzyme Techniques , Keratins/analysis , Male , Mucin-1/analysis , Urinary Bladder Neoplasms/chemistry , Urinary Bladder Neoplasms/surgery
16.
Mycoses ; 44(3-4): 115-8, 2001 May.
Article in English | MEDLINE | ID: mdl-11413923

ABSTRACT

A 65-year-old woman with refractory anaemia who had been treated with systemic corticosteroids for several months developed cryptococcal cellulitis of the right cubital fossa. She was treated empirically for a presumed bacterial cellulitis with little response. Histological examination of debrided tissue revealed Cryptococcus as the causative organism. The tissue reaction involved suppurative inflammation with abscess formation in the dermis and subcutaneous adipose tissue. Necrotizing vasculitis, which has rarely been described in cryptococcosis, was seen in this case. Although the cellulitis was cured by local treatment in this patient, most previous reports recommended systemic antifungal therapy to treat cryptococcal cellulitis.


Subject(s)
Cellulitis/microbiology , Cryptococcosis/microbiology , Cryptococcus , Dermatomycoses/microbiology , Vasculitis/microbiology , Aged , Antifungal Agents/therapeutic use , Cellulitis/drug therapy , Cryptococcosis/drug therapy , Cryptococcus/isolation & purification , Dermatomycoses/drug therapy , Female , Humans , Miconazole/administration & dosage , Miconazole/therapeutic use , Vasculitis/drug therapy
17.
Arch Pathol Lab Med ; 125(5): 665-8, 2001 May.
Article in English | MEDLINE | ID: mdl-11300941

ABSTRACT

A case of malignant gastrointestinal stromal tumor (GIST) is reported. Histologically, spindle cell proliferation with remarkable whorl formations was predominant in the tumor. Immunohistochemically, the tumor cells were diffusely positive for CD117 (c-Kit) and vimentin and partially positive for CD34. Ultrastructurally, the desmosome-like structures and interdigitations occurred much more frequently in the areas with whorl formations. These organelles were considered to be closely associated with the whorl formations. Various kinds of cellular arrangements are revealed in GISTs, but remarkable whorl formations, such as in our case, are a rare variant pattern. Herein, we discuss the histopathologic differences between this and other tumors showing whorl formations and describe the meaning of this unique arrangement. GISTs are thought to be immature tumors, and, therefore, variations in histopathologic findings are recognized. Finally, the ultrastructural study of GISTs is useful for understanding the mechanisms forming whorl formations and the differentiation or pathogenesis of GISTs.


Subject(s)
Gastrointestinal Neoplasms/pathology , Stromal Cells , Aged , Antigens, CD34/metabolism , Female , Gastrointestinal Neoplasms/metabolism , Gastrointestinal Neoplasms/ultrastructure , Humans , Proto-Oncogene Proteins c-kit/metabolism , Vimentin/metabolism
18.
Nihon Igaku Hoshasen Gakkai Zasshi ; 61(1): 25-8, 2001 Jan.
Article in Japanese | MEDLINE | ID: mdl-11218742

ABSTRACT

Transradial angiography has recently emerged as an alternative to the transfemoral or transbrachial approach, especially for coronary or cerebral procedures. However, there are few such studies regarding abdominal angiography. In our institution, we performed abdominal angiography and intervention by the transradial arterial method in 42 cases using a 120-cm-long 4 Fr catheter and compared the results with the transfemoral or transbrachial arterial method and examined the usefulness of this technique. Puncture was successfully carried out in 42 cases, whereas failure occurred in one case, in which the transbrachial method was adopted because of weak pulse. Selective catheter insertion was successful in all cases, after the shape of the catheter had been improved. No serious or dangerous complications occurred during the examinations. In addition, many patients chose the radial arterial method for subsequent examinations on a questionnaire survey we gave patients on the day after we did abdominal angiography by the transradial arterial method. We consider that the transradial arterial method can be used generally in angiography and interventional angiography for abdominal diseases.


Subject(s)
Abdominal Neoplasms/diagnostic imaging , Angiography/methods , Radiography, Interventional/methods , Aged , Brachial Artery , Female , Femoral Artery , Humans , Male , Middle Aged , Radial Artery
20.
Arch Dermatol Res ; 293(9): 460-9, 2001 Sep.
Article in English | MEDLINE | ID: mdl-11758789

ABSTRACT

Tuberous sclerosis complex (TSC) is a multisystemic disorder characterized by systemic hamartomas. Although the disease-determining genes TSC1 and TSC2 have been isolated, the molecular pathogenesis of the disease is not understood. We examined cell cycle abnormalities in skin specimens and cultured cells derived from specific lesions of TSC patients with confirmed TSC1 or TSC2 mutations. None of the specimens used in this study showed loss of heterozygosity (LOH). We detected more cells positive for PCNA and fewer cells positive for MPP2 in the epidermis of TSC patients than in the epidermis of control patients without TSC. Incorporation of 5-bromo-2-deoxyuridine (BrdU) was similar in fibroblasts derived from TSC lesions and in normal human fibroblasts. These results suggest that the cell cycle of TSC cells shows a prolonged S phase. Flow cytometric analysis confirmed S phase prolongation in TSC cells. Many apoptotic cells were detected by a nick end labeling assay in both skin tissue and cultured fibroblasts derived from specific TSC lesions. Examination of cyclin levels showed increased nuclear cyclin A and cytoplasmic cyclin B and decreased nuclear cdc2 levels. We conclude that suppression of either TSC1 or TSC2 may change cyclin levels, prolong S phase and induce apoptotic cell death.


Subject(s)
Apoptosis , S Phase , Tuberous Sclerosis/pathology , Tuberous Sclerosis/physiopathology , Adult , Bromodeoxyuridine , Cells, Cultured , Child , Cyclins/metabolism , Female , Flow Cytometry , Fluorescent Antibody Technique , Humans , Immunohistochemistry , Loss of Heterozygosity , Male , Middle Aged , Mutation , Proteins/genetics , Proteins/metabolism , Repressor Proteins/genetics , Repressor Proteins/metabolism , Skin/metabolism , Staining and Labeling , Tuberous Sclerosis/genetics , Tuberous Sclerosis Complex 1 Protein , Tuberous Sclerosis Complex 2 Protein , Tumor Suppressor Proteins
SELECTION OF CITATIONS
SEARCH DETAIL